주식회사 에스바이오메딕스

{
  "address": "서울특별시 성동구 성수이로26길",
  "brno": "211875****",
  "cappedWarning": false,
  "companyName": "(주)에스바이오메딕스",
  "estimatedAvgAnnualSalary": 49526532,
  "estimatedAvgMonthlySalary": 4127211,
  "fetchedAt": "2026-03-05T11:21:33.258Z",
  "industryCode": "519113",
  "industryName": "상품 종합 도매업",
  "joinDate": "20060701",
  "last12MonthsHired": 3,
  "last12MonthsLeft": 2,
  "last12MonthsNetChange": 1,
  "leaveDate": null,
  "monthlyPensionAmount": 23133020,
  "monthlyTrend": [
    {
      "lostSubscribers": 2,
      "newSubscribers": 3,
      "yearMonth": null
    }
  ],
  "npsRateUsed": 0.095,
  "npsUpperCap": 6370000,
  "seq": "6664988",
  "status": "1",
  "styleCode": "1",
  "subscriberCount": 59,
  "turnoverMonths": 1
}

{
  "address": "서울특별시 성동구",
  "ceo_name": "김동욱, 강세일",
  "certificate": [
    {
      "cert_number": "20070103549",
      "changes": "",
      "disclosure_date": "2007-10-19",
      "first_cert_date": "2007-10-19",
      "no": "1",
      "type": "연구개발유형",
      "valid_period": "2007-10-19 ~ 2009-10-18"
    },
    {
      "cert_number": "20090110093",
      "changes": "",
      "disclosure_date": "2009-11-12",
      "first_cert_date": "2007-10-19",
      "no": "2",
      "type": "연구개발유형",
      "valid_period": "2009-10-19 ~ 2011-10-18"
    },
    {
      "cert_number": "20120300212",
      "changes": "",
      "disclosure_date": "2012-06-21",
      "first_cert_date": "2007-10-19",
      "no": "3",
      "type": "벤처투자유형",
      "valid_period": "2012-06-21 ~ 2014-06-20"
    },
    {
      "cert_number": "20150300242",
      "changes": "",
      "disclosure_date": "2015-06-25",
      "first_cert_date": "2007-10-19",
      "no": "4",
      "type": "벤처투자유형",
      "valid_period": "2015-06-25 ~ 2017-06-24"
    },
    {
      "cert_number": "20170300287",
      "changes": "",
      "disclosure_date": "2017-06-08",
      "first_cert_date": "2007-10-19",
      "no": "5",
      "type": "벤처투자유형",
      "valid_period": "2017-06-25 ~ 2019-06-24"
    },
    {
      "cert_number": "20190300595",
      "changes": "",
      "disclosure_date": "2019-06-27",
      "first_cert_date": "2007-10-19",
      "no": "6",
      "type": "벤처투자유형",
      "valid_period": "2019-06-25 ~ 2021-06-24"
    },
    {
      "cert_number": "20210624010007",
      "changes": "",
      "disclosure_date": "2021-06-24",
      "first_cert_date": "2007-10-19",
      "no": "7",
      "type": "벤처투자유형",
      "valid_period": "2021-06-25 ~ 2024-06-24"
    },
    {
      "cert_number": "20240903020009",
      "changes": "",
      "disclosure_date": "2024-09-03",
      "first_cert_date": "2007-10-19",
      "no": "8",
      "type": "연구개발유형",
      "valid_period": "2024-09-03 ~ 2027-09-02"
    }
  ],
  "company_name": "주식회사 에스바이오메딕스",
  "corp_no": "110111-*******",
  "financials": {
    "2022": {
      "capital_stock": 5109888000,
      "cost_of_sales": 501758000,
      "current_assets": 5430390000,
      "current_liabilities": 8617827000,
      "gross_profit": -140447000,
      "net_income": -7672592000,
      "net_income_bs": -7672593000,
      "non_current_assets": 3424930000,
      "non_current_liabilities": 3802154000,
      "non_operating_expenses": 1299576000,
      "non_operating_income": 163870000,
      "operating_profit": -6536886000,
      "revenue": 361312000,
      "sga_expenses": 6396439000,
      "total_assets": 8855320000,
      "total_equity": -3564661000,
      "total_liabilities": 12419981000
    },
    "2023": {
      "capital_stock": 5668538000,
      "cost_of_sales": 703443000,
      "current_assets": 10012181000,
      "current_liabilities": 4524875000,
      "gross_profit": -412445000,
      "net_income": -8359998000,
      "net_income_bs": -8359999000,
      "non_current_assets": 5063977000,
      "non_current_liabilities": 4990524000,
      "non_operating_expenses": 491071000,
      "non_operating_income": 382995000,
      "operating_profit": -8251922000,
      "revenue": 290998000,
      "sga_expenses": 7839477000,
      "total_assets": 15076158000,
      "total_equity": 5560758000,
      "total_liabilities": 9515400000
    }
  },
  "industry": "물리, 화학 및 생물학 연구개발업",
  "investment": [
    {
      "amount": "2,050,000,000",
      "changes": "2,050,000,000",
      "date": "2018-02-20"
    },
    {
      "amount": "2,000,040,000",
      "changes": "2,000,040,000",
      "date": "2018-02-02"
    }
  ],
  "main_products": "줄기세포 치료제 연구,개발",
  "phone": "02-2205-****",
  "years": [
    2023,
    2022
  ]
}